Cyrrotenohydrazide and its use as a neuraminidase inhibitor
A technology of cyproterohydrazide and neuraminidase, applied in the direction of antiviral agent, organic chemistry, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0018] Preparation of Cyproterohydrazone
[0019](5,6-dimethoxy-1,1a,2,7b-tetrahydrocyclopropane[c]benzopyran-7b-yl)[(R)-4-hydroxy-2-(propene-2 -yl)-2,3-dihydrobenzofuran-5-yl)methanone 2.00g (1.1mmol), dissolved in 20mL ethanol, 1.5mL content is 80% hydrazine hydrate, NaOH solid 0.25g (6.25mmol), 85 It was stirred and refluxed at ℃, tracked by TLC, washed with water after 5 hours, and dried to obtain 1.7 g of white solid with a yield of 86.4%. The melting point is 177-178.5°C. 1 H NMR (CDCl 3 , 400MHz) δ: 1.43~1.47(m, 1H, 1a-H), 1.71(s, 1H, 1-H), 1.77~1.82(m, 3H, CH 3 ), 1.96~2.05(m, 1H, 1-H), 3.01~3.10(m, 1H, 2-H), 3.34~3.39(m, 1H, 2-H), 3.64, 3.73(2×d, J =4.8Hz, 3H, CH 3 0), 3.82(s, 3H, CH 3 O), 4.08(t, J=10.6Hz, 1H, 3'-H), 4.44(t, J=10.6Hz, 1H, 3'-H), 4.92(d, J=10.8Hz, 1H, =CH 2 ), 5.09 (d, J = 10.8Hz, 1H, = CH 2 ), 5.22~5.29(m, 1H, 2′-H), 6.26, 6.37(2×d, 1H, 6-H), 6.50~6.60(m, 2H, 7′-H, 5-H), 7.45 , 7.13 (2 x m, 1H, 6'-H). ESI-MS, m / z: 422.2 (M + , 100%), 423.2...
Embodiment 2
[0021] N'-[(5,6-dimethoxy-1,1a,2,7b-tetrahydrocyclopropane[c]benzopyran-7b-yl][(R)-4-hydroxyl-2- Preparation of (propen-2-yl)-2,3-dihydrobenzofuran-5-yl)methylene]acetylhydrazide
[0022] 20mL of DMF, 0.50g (1.2mmol) of cyproterine hydrazone, 0.3g of potassium carbonate and appropriate amount of molecular sieve, dissolved and added 1.5mL of acetic anhydride, reacted at 80°C, monitored by TLC, washed with brine after reacting for 3h, washed with ethyl acetate (3× 20mL) extraction, desolvation under reduced pressure to obtain 0.47g white solid, yield 84.8%. m.p.113-116°C. 1 H NMR (CDCl 3 , 400MHz) δ: 1.35~1.38(m, 1H, 1a-H), 1.77~1.82(m, 3H, CH 3 ), 1.82~2.05 (m, 3H, CH 3 CO), 2.15, 2.32(2×s, 1H, 1-H), 2.41(s, 1H, 1-H), 3.01~3.07(m, 1H, 2-H), 3.35~3.41(m, 1H, 2-H), 3.63~3.70(m, 3H, CH 3 O), 3.83(s, 3H, CH 3 O), 4.08~4.19(m, 1H, 3′-H), 4.42~4.46(m, 1H, 3′-H), 4.93(s, 1H, =CH 2 ), 5.09 (s, 1H, =CH 2 ), 5.26~5.30(m, 1H, 2′-H), 6.27~6.57(m, 3H, 6-H, 7′-H, 5-H), 7.23, 7.60(2×...
Embodiment 3
[0024] N'-[(5,6-dimethoxy-1,1a,2,7b-tetrahydrocyclopropane[c]benzopyran-7b-yl][(R)-4-hydroxyl-2- Preparation of (propen-2-yl)-2,3-dihydrobenzofuran-5-yl)methylene]propionohydrazide
[0025] Add 0.50 g (1.2 mmol) of cyrroten hydrazone, add 1 mL of propionic anhydride as a solvent, react at 25°C, monitor by TLC, and complete the reaction of the raw materials after 15 minutes. Filtration, extraction with ethyl acetate (3×20mL), and column chromatography gave 0.42g off-white solid, yield 74.2%, m.p.75-80°C, 1 HNMR (CDCl 3 , 400MHz) δ: 1.19~1.31 (m, 3H, CH 3 ), 1.35(m, 1H, 1-H), 1.78(m, 3H, CH 3 ), 1.86, 1.92(2×t, 1H, 1a-H), 1.99~2.24(m, 1H, 1-H), 2.30~2.81(m, 2H, CH 2 CO), 3.06(m, 1H, 2-H), 3.38(m, 1H, 2-H), 3.68(m, 3H, CH 3 O), 3.83(s, 3H, CH 3 O), 4.13(m, 1H, 3'-H), 4.43(m, 1H, 3'-H), 4.92(m, 1H, =CH 2 ), 5.08 (m, 1H, =CH 2 ), 5.27(m, 1H, 2′-H), 6.30~6.59(m, 3H, 6-H, 7′-H, 5-H), 7.20, 7.56(m, 1H, 6′-H), 11.72 (m, 1H, OH). ESI-MS, m / z: 477.2 (M + -1, 100%), 478.2 (M +...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


